Intrinsic reactivity profile of electrophilic moieties to guide covalent drug design: N-α-acetyl-L-lysine as an amine nucleophile

No abstract is available for this paper.

• Publication year

  2016

• Venue

  MedChemComm

• Publication date

  2016-05-19

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1039/C6MD00017G
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Covalent protein modification: the current landscape of residue-specific electrophiles.

  2015cited by this paper
• A Fragment-Based Method to Discover Irreversible Covalent Inhibitors of Cysteine Proteases

  2014cited by this paper
• Chemical and computational methods for the characterization of covalent reactive groups for the prospective design of irreversible inhibitors.

  2014cited by this paper
• Application of the Hard and Soft, Acids and Bases (HSAB) theory to toxicant--target interactions.

  2012cited by this paper
• I and J

  2012cited by this paper
• Kinetic Template‐Guided Tethering of Fragments

  2012cited by this paper
• Measurement and estimation of electrophilic reactivity for predictive toxicology.

  2011cited by this paper
• Discovery of PF-04457845: A Highly Potent, Orally Bioavailable, and Selective Urea FAAH Inhibitor.

  2011cited by this paper
• The resurgence of covalent drugs

  2011cited by this paper
• Involvement of the immune system in idiosyncratic drug reactions.

  2011cited by this paper
• Small Molecule Quantification by Liquid Chromatography-Mass Spectrometry for Metabolites of Drugs and Drug Candidates

  2011cited by this paper
• Strategies for discovering and derisking covalent, irreversible enzyme inhibitors.

  2010cited by this paper
• Characterization of HKI-272 Covalent Binding to Human Serum Albumin

  2010cited by this paper
• How essential is the 'essential' active-site lysine in dihydrodipicolinate synthase?

  2010cited by this paper
• Review of tyrosine and lysine as new motifs for organophosphate binding to proteins that have no active site serine.

  2010cited by this paper
• Kinetic glutathione chemoassay to quantify thiol reactivity of organic electrophiles--application to alpha,beta-unsaturated ketones, acrylates, and propiolates.

  2009cited by this paper
• Multiple roles of the active site lysine of Dopa decarboxylase.

  2009cited by this paper
• A summary of the measured pK values of the ionizable groups in folded proteins

  2008cited by this paper
• Determination of active site of lysine-specific cysteine proteinase (Lys-gingipain) by use of a Porphyromonas gingivalis plasmid system.

  2008cited by this paper
• Quantification of chemical peptide reactivity for screening contact allergens: a classification tree model approach.

  2007cited by this paper
• Mechanism of dihydroneopterin aldolase: functional roles of the conserved active site glutamate and lysine residues.

  2006cited by this paper
• Drug Bioactivation Covalent Binding to Target Proteins and Toxicity Relevance

  2005cited by this paper
• Using mtlser model and am1 hamiltonian in quantitative structure-activity relationship studies of alkyl (1-phenylsulfonyl)cycloalkane-carboxylates

  1997cited by this paper
• Reactivity of chloronitrobenzenes towards glutathione under physiological conditions: the relationship between structure and reaction rate.

  1990cited by this paper
• Reactivity of glutathione with a,-unsaturated ketone flavouring substances

  1989cited by this paper
• Chemical Reagents for Protein Modification

  1984cited by this paper
• Reaction of Glutathione with Conjugated Carbonyls

  1975cited by this paper
• The Dipole Moments of Diphenyl Sulfide, Sulfoxide, Sulfone, and Their Derivatives

  1969cited by this paper
• A comparison of the dipole moments of sulphides, sulphoxides, and sulphones

  1956cited by this paper
• 38. An investigation of the occurrence of the co-ordinate or dative link by electric dipole-moment measurements

  1945cited by this paper

• Application of a MALDI mass spectrometry assay to identify covalent fragments targeting the methyl-lysine reader protein MPP8.

  2026cites this paper
• Research progress on covalent inhibitors targeting alkaline amino acids.

  2025cites this paper
• Recent advances in the design of small molecular drugs with acrylamides covalent warheads.

  2024cites this paper
• Synthesis of aromatic glycoconjugates as anti-fungal agents against Candida spp. and assessment of their covalent crosslinking capabilities.

  2024cites this paper
• Catalytic Lysine745 targeting strategy in fourth-generation EGFR tyrosine kinase inhibitors to address C797S mutation resistance.

  2024cites this paper
• Covalent chemical probes for protein kinases

  2023cites this paper
• The vinyl sulfone motif as a structural unit for novel drug design and discovery

  2023cites this paper
• Development of covalent inhibitors: Principle, design, and application in cancer

  2023cites this paper
• Warheads for designing covalent inhibitors and chemical probes

  2022cites this paper
• Reactivity of Covalent Fragments and Their Role in Fragment Based Drug Discovery

  2022cites this paper
• Fragment Optimization of Reversible Binding to the Switch II Pocket on KRAS Leads to a Potent, In Vivo Active KRASG12C Inhibitor

  2022cites this paper
• Discovery of a Potent and Highly Isoform-Selective Inhibitor of the Neglected Ribosomal Protein S6 Kinase Beta 2 (S6K2)

  2021cites this paper
• Recent progress in covalent warheads for in vivo targeting of endogenous proteins.

  2021cites this paper
• Advances in reversible covalent kinase inhibitors

  2021cites this paper
• Identification of pyrogallol as a warhead in design of covalent inhibitors for the SARS-CoV-2 3CL protease

  2021cites this paper
• Multicomponent reaction–derived covalent inhibitor space

  2021cites this paper
• 10 years into the resurgence of covalent drugs.

  2020cites this paper
• In Vivo Targeting of Endogenous Proteins with Reactive Small Molecules

  2020cites this paper
• Advances in covalent kinase inhibitors.

  2020cites this paper
• Covalent fragment libraries in drug discovery.

  2020cites this paper
• Synthesis and evaluation of novel antifungal agents targeting the fungal plasma membrane H+-ATPase

  2020cites this paper
• Covalent Kinase Inhibitors: An Overview

  2020cites this paper
• Covalent Small Molecules as Enabling Platforms for Drug Discovery

  2019cites this paper
• Covalent binders in drug discovery.

  2019cites this paper
• Structure-based design of targeted covalent inhibitors.

  2018cites this paper
• Selectively Targeting the Kinome-Conserved Lysine of PI3Kδ as a General Approach to Covalent Kinase Inhibition.

  2018cites this paper
• Beyond cysteine: recent developments in the area of targeted covalent inhibition.

  2018cites this paper
• A study of the reactivity of S(VI)-F containing warheads with nucleophilic amino-acid side chains under physiological conditions.

  2017cites this paper
• An Irreversible Inhibitor of HSP72 that Unexpectedly Targets Lysine‐56

  2017cites this paper
• Synthesis of Diverse N-Acryloyl Azetidines and Evaluation of Their Enhanced Thiol Reactivities.

  2017cites this paper
• Lysine-Targeting Covalent Inhibitors.

  2017cites this paper
• Expanding the Armory: Predicting and Tuning Covalent Warhead Reactivity

  2017cites this paper
• Auf Lysin zielende, kovalente Inhibitoren

  2017cites this paper